基于CRISPR的基因驱动在疾病载体Culex quinquefasciatus中产生超门德尔遗传

基于CRISPR的基因驱动在疾病载体Culex quinquefasciatus中产生超门德尔遗传

相关实验视频

Updated: Jun 14, 2026

Embryo Microinjection Techniques for Efficient Site-Specific Mutagenesis in Culex quinquefasciatus

05:59

Embryo Microinjection Techniques for Efficient Site-Specific Mutagenesis in Culex quinquefasciatus

Published on: May 24, 2020

5.6K

Tim Harvey-Samuel¹, Xuechun Feng^2,3, Emily M Okamoto⁴

¹Arthropod Genetics Group, The Pirbright Institute, Woking, GU24 0NF, UK.

Nature communications

|November 21, 2023

概括

研究人员为Culex蚊子开发了CRISPR基因驱动器,这是一种主要的疾病载体. 这项技术显示了有偏见的遗传,为控制这些携带疾病的昆虫提供了新的策略.

科学领域:

遗传学遗传学是一个
载体生物学载体生物学
基因驱动技术 (CRISPR) 是一种基因驱动技术.

背景情况:

昆虫库莱克斯是严重的公共卫生威胁,传播疾病,如西尼罗河病毒.
库莱克斯蚊子的抗虫剂耐药性需要新的控制策略.
基因驱动技术在其他蚊子物种中取得了进步,但在Culex中落后.

研究的目的:

在Culex quinquefasciatus中测试基于CRISPR的指向基因驱动系统.
评估针对不同位置的两个分裂基因驱动转基因的偏向遗传效率.
为了推进基因驱动应用用于Culex蚊子控制.

主要方法:

基于CRISPR的指向基因驱动器的开发和测试.
利用一个表达Cas9的转基因来驱动遗传.
针对两个不同的基因位置与分裂基因驱动转基因.

主要成果:

在Culex quinquefasciatus中证明了两个分裂基因驱动转基因的偏向遗传.
在基因驱动遗传中观察到适度的效率.
将工程指向基因驱动器的应用扩展到Culex属.

结论:

基于CRISPR的指向基因驱动器在Culex蚊子中是可行的.
这项研究为开发基因驱动策略以控制Culex种群提供了基础.
需要进一步开发,以提高基因驱动的效率,以有效控制载体.

更多相关视频

Preparing and Injecting Embryos of Culex Mosquitoes to Generate Null Mutations using CRISPR/Cas9

07:45

Preparing and Injecting Embryos of Culex Mosquitoes to Generate Null Mutations using CRISPR/Cas9

Published on: September 10, 2020

7.0K

Small-Cage Laboratory Trials of Genetically-Engineered Anopheline Mosquitoes

07:45

Small-Cage Laboratory Trials of Genetically-Engineered Anopheline Mosquitoes

Published on: May 1, 2021

2.7K

相关概念视频

01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...

01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...